2Kodama Y,Tao K,Ishida F,et al. Long survival of congenital alveo- lar capillary dysplasia patient with NO inhalation and epopros- tenol : effect of sildenafil, beraprost and bosentan [ J ]. Pediatr Int, 2012,54(6) :923-926.
3Dani C, Pratesi S. Nitric oxide for the treatment of preterm infants with respiratory distress syndrome [ J ]. Expert Opin Pharmacoth- er,2013,14( 1 ) :97-103.
4Ishii T, Motegi T, Hattori K, et al. The association between serum concentration of surfactant protein D and progression of chronic obstructive pulmonary disease [ J ]. J Nippon Med Sch, 2012,579 (6) :498-500.
5Parra E, Alcaraz A, Cruz A, et al. Hydrophobic pulmonary surfac- rant proteins SP-B and SP-C induce pore formation in planar lipid membranes : evidence for proteolipid pores [ J ]. Biophys J, 2013, 104( 1 ) :146-155.
7Js Landry,Menzies D.Occurrence and severity of broncho-pulmo-nary dysplasia and respiratory distress syndrome after a pretermbirth. Journal of Paediatrics and Child Health . 2011
8Tea Stimac,Oleg Petrovic,Robert Krajina.Lamellar body count as a diagnostic test in predicting neonatal respiratory distress syndrome. Croatian Medical Journal . 2012
9Jennifer A. Wambach,Daniel J. Wegner,Kelcey DePass.Single ABCA3 Mutations Increase Risk for Neonatal Respiratory Distress Syndrome. Pediatrics . 2012
